Active Ingredient: MESALAMINE
Proprietary Name: MESALAMINE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 400MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207873
Product Number: 001
Approval Date: May 9, 2019
Applicant Holder Full Name: TEVA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information
